Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 22

    Violation of Market Norms: SEBI imposes Rs 1.15 crore fine on Pharma Company

    Violation of Market Norms: SEBI imposes Rs 1.15 crore fine on Pharma Company

    Medical Dialogues Bureau1 Sept 2019 5:30 AM
    During the investigation, SEBI revealed that the loan paid by Vintage was secured by pledge agreement between Syncom and EURAM Bank.New Delhi: Markets...
    Hospitals permitted to add trade margin on orthopaedic knee implants: NPPA Clarification

    Hospitals permitted to add trade margin on orthopaedic knee implants: NPPA Clarification

    Farhat Nasim31 Aug 2019 9:07 AM
    This clarification comes after the NPPA was informed about certain Third Party Administrators (TPAs) who are not allowing trade margins to Hospitals,...
    AIOCD threatens to Boycott CIPLA if it enters into E-Pharmacy Business

    AIOCD threatens to Boycott CIPLA if it enters into E-Pharmacy Business

    Farhat Nasim31 Aug 2019 9:05 AM
    New Delhi: A lobby of 8.5 lakh chemists across the country is planning to boycott the products manufactured by Cipla if the company enters the e...
    Cracking Down on Spurious Drugs: Union Health Ministry directs States to create Intelligence Cells with CDSCO

    Cracking Down on Spurious Drugs: Union Health Ministry directs States to create Intelligence Cells with CDSCO

    Medical Dialogues Bureau30 Aug 2019 9:27 AM
    These intelligence cells will work in coordination with the officers of state drug departments and the Central Drug Control Standard Organisation...
    Grant of Manufacturing License for Drugs: DTAB recommends amendment of Drugs and Cosmetics Rules, 1945

    Grant of Manufacturing License for Drugs: DTAB recommends amendment of Drugs and Cosmetics Rules, 1945

    Medical Dialogues Bureau29 Aug 2019 10:40 AM
    New Delhi: The Drugs Technical Advisory Board (DTAB) has recently recommended for amendment of the Drugs and Cosmetics Rules, 1945 regarding...
    Regulation of E-Pharmacies: DTAB calls for finalization of rules to regulate online sale, distribution of drugs

    Regulation of E-Pharmacies: DTAB calls for finalization of rules to regulate online sale, distribution of drugs

    Medical Dialogues Bureau28 Aug 2019 11:34 AM
    New Delhi: In light of concerns raised in various forums, the Drugs Technical Advisory Board (DTAB) has recently recommended for finalization of the...
    Chemist license suspended for selling MTP pills sans prescription

    Chemist license suspended for selling MTP pills sans prescription

    Farhat Nasim28 Aug 2019 11:05 AM
    Indore: In a major crackdown, a chemist has been nabbed for selling abortion pills without medical prescription. The authority has suspended his...
    CDSCO committee recommends exemption of chemical contraceptive FDC from Schedule H; Details

    CDSCO committee recommends exemption of chemical contraceptive FDC from Schedule H; Details

    Medical Dialogues Bureau27 Aug 2019 10:20 AM
    The said FDC of centchroman and ethinyloestradiol is a regular oral contraceptive pill sold under various brand names of contraceptive like Mala N,...
    Indian Stent Maker Translumina sells stake to PE Everstone for Rs 500 crore: Report

    Indian Stent Maker Translumina sells stake to PE Everstone for Rs 500 crore: Report

    Farhat Nasim27 Aug 2019 10:01 AM
    Mumbai: Cardiac stents and cardiovascular medical devices maker, Translumina Therapeutics is reported to have sold its minority stake to Private...
    CDSCO preparing list of dual-use APIs imported from unregistered firms

    CDSCO preparing list of dual-use APIs imported from unregistered firms

    Medical Dialogues Bureau26 Aug 2019 8:53 AM
    "The Central Drugs Standard Control Organisation (CDSCO), the Ministry of Health and the Department of Pharmaceuticals want to put a stop to the...
    CDSCO issues advisory on Labelling requirements for MTP combo kit of Misoprostol, Mifepristone tablet, Details

    CDSCO issues advisory on Labelling requirements for MTP combo kit of Misoprostol, Mifepristone tablet, Details

    Medical Dialogues Bureau25 Aug 2019 8:00 AM
    New Delhi: The apex drug regulatory body, Central Drugs Standard Control Organisation(CDSCO) has recently issued an advisory on labelling requirements...
    NPPA fixes MRP of 2 combo drugs manufactured by Emcure, Hetero Labs to prevent HIV; Details

    NPPA fixes MRP of 2 combo drugs manufactured by Emcure, Hetero Labs to prevent HIV; Details

    Farhat Nasim24 Aug 2019 9:52 AM
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    PrevNext

    Popular Stories

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

    Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Healthcare industry lauds Govt decision, says rationalisation of tax structure will provide booster dose to sector

    Healthcare industry lauds Govt decision, says rationalisation of tax structure will provide booster...

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Metropolis Healthcare Q2 profit up 44 pc to Rs 43 crore

    Metropolis Healthcare Q2 profit up 44 pc to Rs 43 crore

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok